Get started
Author

Ruth Rudling

Observed names: R Rudling, Rudling R
Observed institution: Mid Yorkshire Hospitals NHS Trust
OpenAlex ID: A5115976745
Effectiveness and safety of upadacitinib in a real-world cohort of patients with Crohn’s disease in the UK: a multicentre retrospective cohort study
2025 · Yaa Danso, Chandni Radia, et al. · BMJ Open Gastroenterology · 5
PDF
The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis
2026 · Christopher A Lamb, Catherine Picton, et al. · BMJ Open Gastroenterology · 4
PDF
P0832 Real-world effectiveness of risankizumab in Crohn’s Disease: The UK Experience
2025 · A Elford, N Plevris, et al. · Journal of Crohn s and Colitis · 3
Comparative analysis of inflammatory bowel disease (IBD) patient- and service-reported quality of care using 2019 and 2023 UK benchmarking data from more than 26 000 adult patient respondents and 154 IBD services
2026 · A Barney Hawthorne, Paul Christiansen, et al. · Journal of Crohn s and Colitis · 2
Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study
2025 · Chandni Radia, Yaa Danso, et al. · Journal of Crohn s and Colitis · 2
P213 Ustekinumab originator to biosimilar switch: no adverse impact on inflammatory bowel disease control and well tolerated in a multicentre study
2026 · Esha Sharma, Mohammed Allah-Ditta, et al. · E-Posters
PDF
P1139 Switching from ustekinumab originator to biosimilar: No adverse impact on inflammatory bowel disease control and well tolerated by patients in a UK multicentre study
2026 · E Sharma, M Allah-Ditta, et al. · Journal of Crohn s and Colitis
Effectiveness and safety of upadacitinib in a real-world cohort of patients with Crohn’s Disease in the UK: a multicentre retrospective cohort study
· Danso Y, Radia C, et al. · Newcastle University ePrints (Newcastle Univesity)
PDF
Works count: 8
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type